Results 41 to 50 of about 57,061 (258)

Association analysis of class II cytokine and receptor genes in vitiligo patients [PDF]

, 2016
The loss of melanocytes in vitiligo is mainly attributed to defective autoimmune mechanisms and lately autoinflammatory mediators have become more emphasized.
Karelson, Maire, Kingo, Kulli, Koks, Sulev, Ratsep, Ranno, Reimann, Ene, Silm, Helgi, Traks, Tanel, Vasar, Eero   +7 more
core   +1 more source

Artikel asli: Profil Kadar CXCL 10 Serum pada Pasien Vitiligo Di Unit Rawat Jalan Kesehatan Kulit Dan Kelamin RSUD Dr Soetomo Surabaya

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2019
Latar Belakang: Vitiligo adalah penyakit depigmentasi yang paling sering dijumpai dengan manifestasi klinis berupa makula berwarna putih susu berbatas tegas, patogenesis kompleks yang belum dipahami dengan baik sehingga evolusi penyakit tidak dapat ...
Ardhiah Iswanda Putri, Sawitri Sawitri, Diah Mira Indramaya   +2 more
doaj   +1 more source

Development of consensus recommendations on the management of vitiligo and the role of decapeptide in vitiligo by the delphi method

Indian Journal of Dermatology, 2023
Background: Treatment of vitiligo is still a challenge in dermatology. Literature is sparse on the definitive clinical role of basic fibroblast growth factor (bFGF) in vitiligo patients.
Davinder Parsad, Sanjeev Kandhari, Rachita Dhurat, Bela Shah, Imran Majid, Harikishan Kumar Yadalla, Jagdish Sakhiya, Shital Poojary, P Jagadish, Pravin D Banotkar, Ravindra Babu, Y M Shivakumar, S K Bose, Saleem Jamadar, Monal Shah, Bharat Tank, Ravindra Dhabhai, Sanjay Kumar Mittal, Premanshu Bhushan, Akshi Pandita, Vaibhav Barve   +20 more
doaj   +1 more source

The Vitiligo in Senegal [PDF]

ISRN Dermatology, 2012
The aim of our study was to determine the epidemiological and clinical aspects of vitiligo in the largest dermatology department of Senegal. A cross-sectional and descriptive study in a period of 5 months was performed covering all the vitiligo cases. Fifty patients were identified (26 women and 24 men). The mean age was 26.5 years. A family history of
Assane Diop, Boubacar Ahy Diatta, Suzanne Oumou Niang, Mame Thierno Dieng, Maodo Ndiaye, Moussa Diallo, Assane Kane, Sonia Bouksani, Fatimata Ly   +8 more
openaire   +2 more sources

Study of metabolic syndrome in patients of Vitiligo: A single-center observational study

Asian Journal of Medical Sciences, 2022
Background: Metabolic syndrome (MetS) has been observed in patients with vitiligo. Literature suggests that there is some link between vitiligo and MetS. Autoimmunity, oxidative stress, and decreased number of melanocytes are involved in its pathogenesis.
Vishal Gourh , Anita Arya , Anand Dubey , Simmi Dube   +3 more
doaj   +1 more source

A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index [PDF]

, 2017
Background: Actinic keratosis (AK) severity is currently evaluated by subjective assessment of patients. Objectives: To develop and perform an initial pilot validation of a new easy-to-use quantitative tool for assessing AK severity on the head ...
Arkachaisri, Benzekri, Chams-Davatchi, Chen, Chetty, Cockerell, Consensus Report of the European Task Force on Atopic Dermatitis, Feily, Fernandez-Figueras, Fredriksson, Green, Green, Ianhez, Langley, Lee, Mlynek, O'Brien, Olsen, Pandya, Röwert-Huber, Schaefer, Schmitz, Stockfleth, Taieb, Uhlenhake, Wei, Werner, Wolf   +27 more
core   +1 more source

A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature

International Journal of Women's Dermatology, 2020
Hydroxychloroquine (HQ) and quinacrine are widely used antimalarials for systemic lupus erythematosus (SLE) and other autoimmune diseases. We report a case of antimalarial-induced hyperpigmentation in a 57-year old African-American woman. The patient had
Daniel Kwak, Pearl E. Grimes, MD
doaj  

Home interventions and light therapy for treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomized controlled trial [PDF]

, 2018
Vitiligo is a condition resulting in white patches on the skin. People with vitiligo can suffer from low self-esteem, psychological disturbance and diminished quality of life.
Akram, Perways, Batchelor, Jonathan M., Chalmers, J.R., Duley, Lelia, Eleftheriadou, Viktoria, Haines, Rachel H., Hepburn, Trish, Meakin, Garry, Mitchell, Eleanor, Montgomery, Alan A., Ravenscroft, Jane C., Rogers, Andy, Sach, Tracey, Santer, Miriam, Tan, Wei, Thomas, Kim S., White, Jennifer, Whitman, Diane, Williams, Hywel C.   +18 more
core   +3 more sources

Lip vitiligo: a clinico-epidemiological study in a tertiary hospital of South India

Pigment International, 2023
Vitiligo is a common autoimmune pigmentary disorder characterized by destruction of functional melanocytes resulting in the appearance of depigmented patches on the skin and mucosa. These lesions pose a cosmetic challenge.
A. S Savitha, Shashi Kumar BM, Raghunatha Reddy R, Sana Mariam Sankey   +3 more
doaj   +1 more source

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program [PDF]

, 2019
Background: The Italian Renal Cell Cancer Early Access Program was an expanded access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell carcinoma (mRCC) prior to regulatory approval.
Buti, S, Cappuzzo, F, Cartenì, G, Cognetti, F, Cortesi, E, De Giglio, A, De Giorgi, U, Giannarelli, D, Panni, S, Pazzola, A, Porta, C, Procopio, G, Raimondi, A, Rastelli, F, Rossetti, S, Sabbatini, R, Sobrero, A, Sternberg, Cn, Surico, G, Tassinari, D, Tortora, G, Turci, D, Verzoni, E   +22 more
core   +3 more sources